期刊文献+

A novel method for evaluating the dynamic biocompatibility of degradable biomaterials based on real-time cell analysis 被引量:5

原文传递
导出
摘要 Degradable biomaterials have emerged as a promising type of medical materials because of their unique advantages of biocompatibility,biodegradability and biosafety.Owing to their bioabsorbable and biocompatible properties,magnesium-based biomaterials are considered as ideal degradable medical implants.However,the rapid corrosion of magnesium-based materials not only limits their clinical application but also necessitates a more specific biological evaluation system and biosafety standard.In this study,extracts of pure Mg and its calcium alloy were prepared using different media based on ISO 10993:12;the Mg^2+ concentration and osmolality of each extract were measured.The biocompatibility was investigated using the MTT assay and xCELLigence real-time cell analysis(RTCA).Cytotoxicity tests were conducted with L929,MG-63 and human umbilical vein endothelial cell lines.The results of the RTCA highly matched with those of the MTT assay and revealed the different dynamic modes of the cytotoxic process,which are related to the differences in the tested cell lines,Mg-based materials and dilution rates of extracts.This study provides an insight on the biocompatibility of biodegradable materials from the perspective of cytotoxic dynamics and suggests the applicability of RTCA for the cytotoxic evaluation of degradable biomaterials.
出处 《Regenerative Biomaterials》 SCIE 2020年第3期321-329,共9页 再生生物材料(英文版)
基金 supported by the National Key Research and Development Project of China(NO.2016YFC1103205).
作者简介 Yanping Shi,Correspondence address.Department of Biological Evaluation,Shandong Quality Inspection Center for Medical Devices,No.15166 Century Avenue,H-T Industrial Development Zone,Jinan 250101,China.Tel:+86-0531-82682920,Fax:+86-0531-82682930,E-mail:sdzxsyp@163.com;Xiaoxiao Gai,contributed equally to this work;Chenghu Liu,contributed equally to this work。
  • 相关文献

参考文献5

二级参考文献157

  • 1G.L. Song, S.Z. Song, Adv. Eng. Mater. 9 (2007) 298-302.
  • 2F. Witte, V. Kaese, H. Haferkamp, E. Switzer, A. Meyer-Lindenberg, C.J. Wirth, H. Windhagen, Biomaterials 26 (2005) 3.
  • 3J.C. Gao, S. Wu, L.Y. Qiao, Y. Wang, Trans. Nonferrous Met. Soc. China 18 (2008) 588-592.
  • 4B. Heublein, R. Rohde, V. Kaese, M. Niemeyer, W. Hartung, A. Haverich, Heart 89 (2003) 651-656.
  • 5C.D. Mario, H. Griffiths, O. Goktekin, J. Interv. Cardiol. 17 (2004) 391-395.
  • 6P. Peeters, M. Bosiers, J. Verbist, K. Deloose, B. Heublein, J. Endovascular Ther. 12 (2005) 1-5.
  • 7R. Erbel, C. Di Mario, J. Bartunek, J. Bonnier, B. de Bruyne, F.R. Eberli, P. Erne, M. Haude, B. Heublein, M. Horriga.
  • 8R. Waksman, EuroIntervention 5 (2009) FI03-FI08.
  • 9S.S.A. El-Rahman, Pharmacol. Res. 47 (2003) 189-194.
  • 10Y Nakamura, Y Tsumura, Y. Tonogai, T. Shibata, Y Ito, Toxicol. Sci. 37 (1997) 106-116.

共引文献160

同被引文献173

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部